Co-located with the Pharmaceutical Packaging and Labelling Summit

09 - 11 June, 2020 | Crowne Plaza Zurich, Zurich, Switzerland

Post Conference Workshop Day

8:30 am - 9:00 am Morning Coffee and Registration

9:00 am - 12:00 pm Moving Beyond Compliance – Transitioning from Serialisation to Securitisation

For the past three years, much of the product security efforts have centered on FMD, MDR and DSCSA compliance ahead of the regulatory deadlines. With the FMD deadline behind us now, and 2023 rapidly approaching, the industry must look beyond compliance and assess where serialisation and traceability can fit into a broader product security strategy.

This workshop focuses on identifying and maximising the value beyond compliance in your serialisation and traceability systems. With discussions centering around analytical outcomes and the utilisation of data collected, this workshop is designed to help you build on your regulatory traceability compliance and develop a holistic brand protection strategy.

In this workshop, you will:

·  Discuss the global serialisation and traceability requirements to identify similarities and differences in approach, with reference to both drug and medical device supply
· Examine the outcomes generated from traceability compliance: How can we look to utilise these systems for additional product and supply chains securitisation?
· Analyse where FMD, MDR and DSCSA compliance fit into a broader product and supply chain protection strategy, and where further development is needed
· Identify areas of further investment or opportunity: Mapping the value in future product protection and supply chain securitisation to ensure viable ROI 

12:00 pm - 1:00 pm Networking Lunch

1:00 pm - 4:00 pm Facilitating Public and Private Sector Collaboration: Coordinating to Combat Fraudulent Medicines, Minimise Brand and Product Risks, and Enable Effective Data Sharing

Cross-Industry studies continue to show that the most effective methods of combatting illicit and substandard trade of product requires effective public and private sector collaboration – a model that the pharmaceutical industry can certainly apply to strengthen their global product securitisation.

By assessing your global supply chain weaknesses, and mapping this against public sector expertise, this interactive workshop will help to identify effective methods of facilitating collaboration across NGOs, international government agencies and the private sector. Additional focus will be given to the most effective ways of facilitating this communication through data sharing, information prioritisation and joint venture projects.

In this workshop, you will:

·  Discuss the global trade landscape of fraudulent, counterfeit and substandard medicines to identify possible market trends and potential indicators
· Identify areas of public sector focus and prioritisation to align your efforts and global securitisation goals
· Analyse the most effective methods of engaging in cross sector dialogue to generate the most impact for your securitisation efforts
· Identify and discuss the value of areas of further value, such as data sharing and joint venture projects or taskforces